CLCN2 and attention deficit-hyperactivity disorder: In sporadic patients, a heterozygous CLCN2 G161S was identified in a male patient with GTS and attention deficit hyperactivity disorder (ADHD) and a female patient with GTS and obsessive–compulsive disorder (OCD), and the 489 controls all carried the wild-type allele (Figure 2).